Clinical Study for Safety and Immunogenicity Study of Influenza Vaccine
Clinical trial NCT01617239 · COMPLETED
Trial details
- NCT number
- NCT01617239
- Sponsor
- Crucell Holland BV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-06-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.